STAAR Surgical (NASDAQ:STAA) holders should vote against Alcon's (ALC) planned $1.5 billion purchase of the implantable lens ...

STAAR responded by saying, “We urge all STAAR stockholders not to be misled by Broadwood. STAAR is confident that the Alcon transaction maximizes value for STAAR stockholders [and] is the only merger ...

The $28-a-share sale of STAAR Surgical Company (NASDAQ:STAA) to Alcon AG (NYSE:ALC) has become one of the most intriguing takeover stories of recent memory. Since the merger announcement in August, ...

The tension between STAAR and Broadwood Partners continues as both have issued further statements for and against the ...

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

Alcon has experienced robust Q1 growth, driven by double-digit growth in vision care, particularly in the contact lens market. The company's strong revenue growth is attributed to successful product ...

Key opportunities in the global vision care market lie in innovative product enhancements across eyeglass lenses, contact ...

The bankrupt studio behind the “Matrix” saga is dismissing Warner Bros. Entertainment’s attempt to acquire its assets instead of Alcon Media Group, calling the media giant’s arguments logically ...

Alcon has bought up Belkin Vision and its laser device for treating glaucoma. The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus the opportunity for up to ...